How much funding has BaroPace raised?

BaroPace has disclosed $940K raised across 2 rounds.

Where is BaroPace headquartered?

BaroPace is headquartered in Issaquah, US.

BaroPace

Issaquah, US · Founded 2020 · Delaware corporation

BaroPace is developing PressurePace, a closed-loop system that adjusts a cardiac pacemaker in response to real-time blood pressure measurements to treat drug-resistant hypertension and common forms of heart failure. The technology is based on the theory and clinical data of Dr. Michael Burnam linking declining heart rate to hypertensive disease and heart failure.

Hardware Healthtech Medical Devices

Founders & leadership

Michael BurnamFounder

Jessica BurnamNamed on SEC filing

Board

Eli GangBoard director

Mike CoyleBoard director

Bradley BurnamBoard director

Reported raises · per SEC filings

Form D private placements

$940K disclosed across 2 rounds · 2020–2024

▶$365KraisedSep 2024 · 5 investors · Other Technology

Rule 506(b)

Officers, directors & promoters on the filing

Eli GangDirector
Mike CoyleDirector
Michael BurnamExecutive Officer, Director
Bradley BurnamDirector

Offering amount: $4M
Amount sold: $365K
First sale: Aug 2024
Incorporated: Corporation, Delaware, 2020
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$575KraisedDec 2020 · 6 investors · Other Technology

Rule 506(b)

Officers, directors & promoters on the filing

Michael BurnamExecutive Officer, Director, Promoter
Bradley BurnamDirector
Eli GangDirector, Promoter
Jessica BurnamExecutive Officer, Promoter

Offering amount: $1.5M
Amount sold: $575K
Sales commissions: $96.3K
Placement agents: Cahn Capital Corp.
First sale: Jun 2020
Incorporated: Corporation, Delaware, 2018
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 3

by search overlap

Crew324 shared keywordsCrew32 maintains a database of compensation and workplace culture information that companies can compare against industry benchmarks. Its data is segmented by factors such as gender, experience level, region and company size, and includes startup salary figures indexed to the amount of venture funding a company has raised.

NeuroPace4 shared keywordsNeuroPace is a commercial-stage medical device company that develops the RNS System, a brain-responsive neurostimulation platform delivering real-time treatment at the seizure source for patients with drug-resistant epilepsy and other brain disorders.

Outpace Bio3 shared keywordsOutpace Bio develops engineered protein technologies and cell therapies to treat solid tumors, focusing on protein design and T cell engineering to improve cancer treatment efficacy and safety.

Companies competing with BaroPace for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does BaroPace do?: BaroPace is developing PressurePace, a closed-loop system that adjusts a cardiac pacemaker in response to real-time blood pressure measurements to treat drug-resistant hypertension and common forms of heart failure. The technology is based on the theory and clinical data of Dr. Michael Burnam linking declining heart rate to hypertensive disease and heart failure.
How much funding has BaroPace raised?: BaroPace has disclosed $940K raised across 2 rounds.
Where is BaroPace headquartered?: BaroPace is headquartered in Issaquah, US.